questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Signes et symptômes respiratoires
Hyperventilation
Hyperventilation : Questions médicales fréquentes
Termes MeSH sélectionnés :
Angiotensin Receptor Antagonists
Diagnostic
5
Hyperventilation
Diagnostic médical
Gaz du sang
Hyperventilation
Anxiété
Troubles respiratoires
Signes cliniques
Hyperventilation
Fréquence respiratoire
Hyperventilation
Symptômes
5
Symptômes
Hyperventilation
Douleurs thoraciques
Hyperventilation
Épisodes de stress
Hyperventilation
Prévention
5
Gestion du stress
Hyperventilation
Exercices de respiration
Hyperventilation
Éducation sur l'anxiété
Hyperventilation
Méditation
Hyperventilation
Traitements
5
Thérapie cognitivo-comportementale
Hyperventilation
Anxiété
Thérapie comportementale
Anxiolytiques
Hyperventilation
Respiration diaphragmatique
Hyperventilation
Hospitalisation
Hyperventilation
Complications
5
Troubles électrolytiques
Hyperventilation
Palpitations
Hyperventilation
Santé mentale
Hyperventilation
Problèmes respiratoires
Hyperventilation
Facteurs de risque
5
Athlètes
Hyperventilation
Tabagisme
Hyperventilation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hyperventilation : Questions médicales les plus fréquentes",
"headline": "Hyperventilation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hyperventilation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-06",
"dateModified": "2025-03-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hyperventilation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Signes et symptômes respiratoires",
"url": "https://questionsmedicales.fr/mesh/D012818",
"about": {
"@type": "MedicalCondition",
"name": "Signes et symptômes respiratoires",
"code": {
"@type": "MedicalCode",
"code": "D012818",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.852"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hyperventilation",
"alternateName": "Hyperventilation",
"code": {
"@type": "MedicalCode",
"code": "D006985",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Naoto Fujii",
"url": "https://questionsmedicales.fr/author/Naoto%20Fujii",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Health and Sport Sciences, University of Tsukuba , Tsukuba , Japan."
}
},
{
"@type": "Person",
"name": "Takeshi Nishiyasu",
"url": "https://questionsmedicales.fr/author/Takeshi%20Nishiyasu",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Health and Sport Sciences, University of Tsukuba , Tsukuba , Japan."
}
},
{
"@type": "Person",
"name": "Eun Hye Oh",
"url": "https://questionsmedicales.fr/author/Eun%20Hye%20Oh",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Pusan National University School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea."
}
},
{
"@type": "Person",
"name": "Seo Young Choi",
"url": "https://questionsmedicales.fr/author/Seo%20Young%20Choi",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea."
}
},
{
"@type": "Person",
"name": "Thomas Ritz",
"url": "https://questionsmedicales.fr/author/Thomas%20Ritz",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Synthesis, Characterization and Application of a MIP-polyHIPE for Selective Extraction of Angiotensin II Receptor Antagonists Residues in Natural Waters.",
"datePublished": "2023-03-10",
"url": "https://questionsmedicales.fr/article/36981793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20064878"
}
},
{
"@type": "ScholarlyArticle",
"name": "Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT",
"datePublished": "2022-08-15",
"url": "https://questionsmedicales.fr/article/35969296",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11357-022-00639-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Decoding Angiotensin Receptors: TOMAHAQ-Based Detection and Quantification of Angiotensin Type-1 and Type-2 Receptors.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37681524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1161/JAHA.123.030791"
}
},
{
"@type": "ScholarlyArticle",
"name": "Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39264627",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.32862"
}
},
{
"@type": "ScholarlyArticle",
"name": "Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36459752",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.amjcard.2022.10.026"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes respiratoires",
"item": "https://questionsmedicales.fr/mesh/D012818"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hyperventilation",
"item": "https://questionsmedicales.fr/mesh/D006985"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hyperventilation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hyperventilation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hyperventilation",
"description": "Comment diagnostiquer l'hyperventilation ?\nQuels tests sont utilisés pour l'hyperventilation ?\nL'hyperventilation peut-elle être confondue avec d'autres conditions ?\nQuels signes cliniques indiquent l'hyperventilation ?\nL'hyperventilation est-elle mesurable ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Angiotensin+Receptor+Antagonists#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hyperventilation",
"description": "Quels sont les symptômes courants de l'hyperventilation ?\nL'hyperventilation provoque-t-elle des douleurs thoraciques ?\nPeut-on ressentir de l'anxiété avec l'hyperventilation ?\nL'hyperventilation entraîne-t-elle une fatigue ?\nLes symptômes de l'hyperventilation sont-ils permanents ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Angiotensin+Receptor+Antagonists#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hyperventilation",
"description": "Comment prévenir l'hyperventilation ?\nLes exercices de respiration aident-ils à prévenir l'hyperventilation ?\nL'éducation sur l'anxiété peut-elle prévenir l'hyperventilation ?\nLe yoga peut-il aider à prévenir l'hyperventilation ?\nLes techniques de méditation sont-elles utiles ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Angiotensin+Receptor+Antagonists#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hyperventilation",
"description": "Quels traitements sont disponibles pour l'hyperventilation ?\nComment la thérapie comportementale aide-t-elle ?\nLes médicaments sont-ils nécessaires pour l'hyperventilation ?\nQuelles techniques de respiration sont recommandées ?\nL'hyperventilation nécessite-t-elle une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Angiotensin+Receptor+Antagonists#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hyperventilation",
"description": "Quelles complications peuvent survenir avec l'hyperventilation ?\nL'hyperventilation peut-elle causer des évanouissements ?\nDes troubles cardiaques peuvent-ils être liés à l'hyperventilation ?\nL'hyperventilation peut-elle affecter la santé mentale ?\nY a-t-il des risques à long terme liés à l'hyperventilation ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Angiotensin+Receptor+Antagonists#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hyperventilation",
"description": "Quels sont les facteurs de risque de l'hyperventilation ?\nL'anxiété est-elle un facteur de risque ?\nLes athlètes sont-ils plus à risque d'hyperventilation ?\nLes maladies pulmonaires augmentent-elles le risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006985?mesh_terms=Angiotensin+Receptor+Antagonists#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hyperventilation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et l'évaluation des symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'hyperventilation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de gaz du sang peuvent être effectués pour évaluer les niveaux de CO2."
}
},
{
"@type": "Question",
"name": "L'hyperventilation peut-elle être confondue avec d'autres conditions ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec l'anxiété ou des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent l'hyperventilation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des palpitations, des étourdissements et des picotements peuvent indiquer l'hyperventilation."
}
},
{
"@type": "Question",
"name": "L'hyperventilation est-elle mesurable ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être mesurée par la fréquence respiratoire et les niveaux de CO2 dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'hyperventilation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des vertiges, des palpitations, et des sensations de picotement."
}
},
{
"@type": "Question",
"name": "L'hyperventilation provoque-t-elle des douleurs thoraciques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs thoraciques dues à une tension musculaire."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir de l'anxiété avec l'hyperventilation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperventilation peut être à la fois un symptôme et un déclencheur d'anxiété."
}
},
{
"@type": "Question",
"name": "L'hyperventilation entraîne-t-elle une fatigue ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue peut survenir en raison d'une respiration inefficace et d'une hyperoxie."
}
},
{
"@type": "Question",
"name": "Les symptômes de l'hyperventilation sont-ils permanents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont généralement temporaires et liés à des épisodes de stress ou d'anxiété."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hyperventilation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par la gestion du stress, des techniques de relaxation et une respiration consciente."
}
},
{
"@type": "Question",
"name": "Les exercices de respiration aident-ils à prévenir l'hyperventilation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices réguliers de respiration peuvent aider à stabiliser le rythme respiratoire."
}
},
{
"@type": "Question",
"name": "L'éducation sur l'anxiété peut-elle prévenir l'hyperventilation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'anxiété et ses effets peut réduire les épisodes d'hyperventilation."
}
},
{
"@type": "Question",
"name": "Le yoga peut-il aider à prévenir l'hyperventilation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le yoga favorise la relaxation et améliore la conscience respiratoire."
}
},
{
"@type": "Question",
"name": "Les techniques de méditation sont-elles utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la méditation aide à réduire le stress et à réguler la respiration."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour l'hyperventilation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des techniques de respiration, la thérapie cognitivo-comportementale et des médicaments."
}
},
{
"@type": "Question",
"name": "Comment la thérapie comportementale aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle aide à gérer l'anxiété et à modifier les comportements de respiration inappropriés."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils nécessaires pour l'hyperventilation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais des anxiolytiques peuvent être prescrits si l'anxiété est sévère."
}
},
{
"@type": "Question",
"name": "Quelles techniques de respiration sont recommandées ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la respiration diaphragmatique et la respiration lente sont recommandées."
}
},
{
"@type": "Question",
"name": "L'hyperventilation nécessite-t-elle une hospitalisation ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, sauf en cas de complications graves ou de crises d'anxiété sévères."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hyperventilation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles électrolytiques, des spasmes musculaires et des évanouissements."
}
},
{
"@type": "Question",
"name": "L'hyperventilation peut-elle causer des évanouissements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une hyperventilation sévère peut entraîner des évanouissements en raison d'une hypoxie."
}
},
{
"@type": "Question",
"name": "Des troubles cardiaques peuvent-ils être liés à l'hyperventilation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hyperventilation peut provoquer des palpitations et des douleurs thoraciques, mais rarement des troubles cardiaques graves."
}
},
{
"@type": "Question",
"name": "L'hyperventilation peut-elle affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut exacerber l'anxiété et mener à des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme liés à l'hyperventilation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des risques à long terme incluent des problèmes respiratoires chroniques et des troubles anxieux."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hyperventilation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le stress, l'anxiété, les troubles respiratoires et certaines conditions médicales."
}
},
{
"@type": "Question",
"name": "L'anxiété est-elle un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété est un facteur majeur qui peut déclencher des épisodes d'hyperventilation."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils plus à risque d'hyperventilation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les athlètes peuvent hyperventiler lors d'efforts intenses ou de stress compétitif."
}
},
{
"@type": "Question",
"name": "Les maladies pulmonaires augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme l'asthme ou la BPCO peuvent augmenter le risque d'hyperventilation."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut aggraver les problèmes respiratoires et augmenter le risque d'hyperventilation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Faculty of Health and Sport Sciences, University of Tsukuba , Tsukuba , Japan.
Publications dans "Hyperventilation" :
3 publications dans cette catégorie
Affiliations :
Faculty of Health and Sport Sciences, University of Tsukuba , Tsukuba , Japan.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Pusan National University School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
School of Physical Education, Sport & Exercise Science, University of Otago, Dunedin, Otago, New Zealand.
Centre for Heart, Lung and Vascular Health, School of Health and Exercise Science, University of British Columbia-Okanagan, Kelowna, British Columbia, Canada.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
John Rankin Laboratory for Pulmonary Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Surgical Sciences, University of Otago, Dunedin, Otago, New Zealand.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Surgical Sciences, University of Otago, Dunedin, Otago, New Zealand.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
School of Physical Education, Sport & Exercise Science, University of Otago, Dunedin, Otago, New Zealand.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, University of Otago, Dunedin, Otago, New Zealand.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Centre for Heart, Lung and Vascular Health, School of Health and Exercise Science, University of British Columbia-Okanagan, Kelowna, British Columbia, Canada.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
School of Physical Education, Sport & Exercise Science, University of Otago, Dunedin, Otago, New Zealand.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Development, Adaptation and Disadvantage, Cardiorespiratory Regulations and Motor Control (EA 3450 DevAH) Research Unit, University of Lorraine, 9 Avenue de la Forêt de Haye, 54505, Vandoeuvre-lès-Nancy, France; University Centre of Sports Medicine and Adapted Physical Activity, Department of Pulmonary Function Testing and Exercise Physiology, 9 Rue du Morvan, 54511, Vandoeuvre-lès-Nancy, France.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Faculty of Psychology, University of Warsaw, Stawki 5/7, 00-183, Warsaw, Poland. mikolaj.szulczewski@psych.uw.edu.pl.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Institute for Intensive Care Medicine, University Hospital of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland. giovanna.brandi@usz.ch.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Institute for Intensive Care Medicine, University Hospital of Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
Publications dans "Hyperventilation" :
2 publications dans cette catégorie
Affiliations :
Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
Publications dans "Hyperventilation" :
Polymers via high internal phase emulsion (polyHIPEs) were molecularly imprinted with Irbesartan, an antihypertensive drug belonging to the class of angiotensin II receptor antagonists (sartan drugs),...
The reported primary dementia-protective benefits of angiotensin II type 1 receptor (AT...
Background The renin-angiotensin system plays a crucial role in human physiology, and its main hormone, angiotensin, activates 2 G-protein-coupled receptors, the angiotensin type-1 and type-2 receptor...
Thrombotic microangiopathy (TMA) on kidney biopsy is a pattern of endothelial injury commonly seen in malignant hypertension (mHTN), but treatment strategies are not well established....
To evaluate the kidney outcomes of angiotensin receptor-neprilysin inhibitor (ARNI), specifically sacubitril/valsartan, vs angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocke...
This single-center cohort study enrolled consecutive patients in China diagnosed with mHTN-associated TMA through kidney biopsy from January 2008 to June 2023. Follow-up was conducted until the conclu...
Treatment with sacubitril/valsartan or ACEI/ARBs during hospitalization and after discharge....
The primary outcome was a composite of kidney recovery: a 50% decrease in serum creatinine level, decrease in serum creatinine levels to the reference range, or kidney survival free from dialysis for ...
Among the 217 patients (mean [SD] age, 35.9 [8.8] years; 188 men [86.6%]) included in the study, 66 (30.4%) received sacubitril/valsartan and 151 (69.6%) received ACEI/ARBs at baseline. Sacubitril/val...
In this cohort study, sacubitril/valsartan treatment was associated with a potential kidney function benefit in patients with mHTN-associated TMA compared with ACEI/ARB treatment. The findings suggest...
The superiority of angiotensin receptor-neprilysin inhibitor (ARNI) over angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin receptor blocker (ARB) has not been reassessed after the public...
Medications used to treat hypertension may affect fracture risk. This study investigated fracture risk for users of angiotensin converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers ...
Angiotensin receptor blockers (ARBs) used in the treatment of hypertension and potentially in SARS-CoV-2 infection exhibit inverse agonist effects at angiotensin AR1 receptors, suggesting the receptor...
The aim of this study was to conduct a systematic review and meta-analysis to investigate the effect of the premorbid use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker...
Embase, the Cochrane Central Register of Controlled Trials, and MEDLINE were searched for studies based on the below eligibility criteria. The protocol was registered at the PROSPERO (CRD42022309129)....
Eligibility criteria were as follows: (1) randomized controlled trials, cohort studies, cross-sectional studies, (2) patients with sepsis aged ≥16 years, and (3) received premorbid ACEI/ARB, or not....
The patient and study characteristics and outcomes were extracted. All analyses were presented with the use of random-effects models. The primary outcome was short-term mortality defined as ≤30-day, i...
Fifteen studies (N = 96,159) met the eligibility criteria. Of these, eleven studies (N = 40,360) reported unadjusted short-term mortalities. The pooled odds ratio (OR) of short-term mortality with the...
In this meta-analysis, the premorbid ACEI/ARB was associated with significantly lower short-term mortality in patients with sepsis despite the significantly higher risk of AKI....
Guidelines suggest that adults with diabetes and kidney disease receive treatment with angiotensin-converting-enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). This is an update of a Co...
We compared the efficacy and safety of ACEi and ARB therapy (either as monotherapy or in combination) on cardiovascular and kidney outcomes in adults with diabetes and kidney disease....
We searched the Cochrane Kidney and Transplants Register of Studies to 17 March 2024 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register...
We included studies evaluating ACEi or ARB alone or in combination, compared to each other, placebo or no treatment in people with diabetes and kidney disease....
Two authors independently assessed the risk of bias and extracted data. Summary estimates of effect were obtained using a random-effects model, and results were expressed as risk ratios (RR) and their...
One hundred and nine studies (28,341 randomised participants) were eligible for inclusion. Overall, the risk of bias was high. Compared to placebo or no treatment, ACEi may make little or no differenc...
ACEi or ARB may make little or no difference to all-cause and cardiovascular death compared to placebo or no treatment in people with diabetes and kidney disease but may prevent kidney failure. ARB ma...
For persons with proteinuria, angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) are treatment mainstays for reducing kidney disease progression. Guidelines f...